Targeted radiation 'Vaccine' revives failed immunotherapy in desperate lung cancer patients
NCT ID NCT07423169
Summary
This study is testing a new combination treatment for patients with advanced, inoperable lung cancer who have no other options left. It combines a very precise, high-dose radiation shot to only part of the tumor with a drug that helps the immune system fight cancer. The goal is to see if this 'rechallenge' can restart the immune system's attack and control the cancer for longer than the drug did alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radiation Oncology Department
RECRUITINGKrems, Austria, 3500, Austria
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.